Soligenix Inc Stock OTC Bulletin Board
Equities
US8342232084
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 708K 967K | Sales 2025 * | 900K 1.23M | Capitalization | 5.47M 7.46M |
---|---|---|---|---|---|
Net income 2024 * | -8M -10.92M | Net income 2025 * | -9M -12.28M | EV / Sales 2024 * | 7.72 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.07 x |
P/E ratio 2024 * |
-0.75
x | P/E ratio 2025 * |
-0.86
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.93% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 06-07-31 | |
Jonathan Guarino
DFI | Director of Finance/CFO | 51 | 19-09-10 |
Richard Straube
CTO | Chief Tech/Sci/R&D Officer | 72 | 14-01-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 06-07-31 | |
Gregg Lapointe
BRD | Director/Board Member | 65 | 09-02-28 |
Robert Rubin
BRD | Director/Board Member | 78 | 09-09-30 |
1st Jan change | Capi. | |
---|---|---|
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |